Distribution of Biglycan and Decorin in Collateral and Cruciate Ligaments and Menisci of the Rabbit Knee Joint

Abstract

The small leucine-rich proteoglycans (PGs) biglycan and decorin, and their mRNAs, have been localized during neonatal development and aging (3 weeks to 2 years) of collateral and cruciate ligaments and of menisci of the rabbit knee joint. In the collateral ligaments, biglycan and decorin are found between the bundles of collagen fibers at all ages. In cruciate ligaments the PGs are primarily around the cells. In neonatal ligaments all the cells express the mRNAs for biglycan and decorin, but in the collateral ligaments the number expressing the mRNAs is reduced at 8 months. In 3–week menisci the PGs are uniformly distributed in the matrix, but by 8 months biglycan is present primarily in the central fibrocartilaginous regions, whereas decorin is found peripherally. In neonates, all the cells express the mRNAs but the number is reduced in 8-month menisci. The results illustrate the precise localizations of biglycan and decorin in healthy rabbit ligaments and menisci which, after injury, must be reproduced in the repair tissue for normal strength to be regained.

Keywords

biglycan decorin proteoglycans mRNAs rabbit knee joint ligaments menisci in situ hybridization immunohistochemistry

The knee is a hinge joint that is stabilized by ligaments and menisci. The collateral ligaments restrict the lateral and medial displacement of the femur and tibia relative to each other, while the cruciate ligaments prevent anterior or posterior movement. The menisci deepen the articulating surfaces of the tibial plateau. All are therefore crucial for stability of the knee joint and all are subject to injury, particularly in athletes, which may lead to the development of osteoarthritis. Experimental models of osteoarthritis frequently involve the transection of the collateral and cruciate ligaments and/or the menisci (see, e.g., Pond and Nuki 1973; Hashimoto et al. 1998; Neidel et al. 1998).

Ligaments and tendons are composed of bundles of collagen fibrils, of which the major component is Type I, but Types III, V, and VI collagen are also present (Amiel et al. 1984; Bray et al. 1993; Bland and Ashhurst 1996a, 1997). The organization of the fibrillar collagens changes during fetal and postnatal development in both the collateral and cruciate ligaments (Bland and Ashhurst 1996a). Most studies of the proteoglycans (PGs) of ligaments relate to their glycosaminoglycan (GAG) content and are biochemical. In bovine collateral ligaments there are two populations of PGs. The larger population consists of small chondroitin sulfate/dermatan sulfate PGs, most of which are decorin, whereas the smaller population (about 20%) consists of large chondroitin sulfate/keratan sulfate PGs (Hey et al. 1990). One large chondroitin sulfate PG in bovine collateral ligament was identified as versican-like (Campbell et al. 1996). Chondroitin and dermatan sulfates and hyaluronan are present in collateral and cruciate ligaments of human and several other animals (Gässler et al. 1994; Watanabe et al. 1994).

Most mammalian menisci are fibrocartilaginous. The major collagen of menisci is Type I, but Types II, III, V, and VI collagen may also be present (Eyre and Wu 1983; Cheung 1987; McDevitt and Webber 1990; Bland and Ashhurst 1996b). In rabbit fetal menisci, Types I, III, and V collagen are present, but at 3 weeks postnatal Type II collagen appears in the central region (Bland and Ashhurst 1996b). There is little overlap of the regions containing Types I and II collagen in adult menisci, whereas Types III and V collagen are found throughout the tissue.

Table 1

Binding of antibodies to biglycan and decorin in the matrix and expression of their mRNAs by cells of the collateral and cruciate ligaments and menisci a

	Biglycan								Decorin
	LCL		MCL		Cruciate		Menisci		LCL		MCL		Cruciate		Menisci
Age	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA
3 weeks	±/+	+	±/+	+	+ +	+	±/+	+	±/+	+	±/+	+	+	+	±/+	+
6 weeks	±/+	+	±/+	+	+ +	+	±/+	+	±/+	+	±/+	+	+	+	±/+	+
14 weeks	±	+	+	+	+	+	+	+	±/+	+	±/+	+	+	+	±/+	+
8 months	±	−/+	±	−/+	+	+	+	−/+	±/+	−/+	±/+	−/+	+	+	±/+	−/+
2 years	±/+	−/+	±	−/+	+	+	+	−/+	±/+	−/+	±	−/+	+	+	±/+	−/+

^aLCL, lateral collateral ligament; MCL, medial collateral ligament; Proteins: + + = antibody bound strongly; + = antibody bound; ± = antibody bound weakly; – antibody not bound. mRNAs: + most cells positive; −/+, few cells positive.

In adult pig and rabbit menisci the major GAG is chondroitin-6-sulfate, but there is some chondroitin-4-sulfate and dermatan sulfate (Webber et al. 1984; Scott et al. 1997). In the 20-week porcine meniscus biglycan is more abundant than decorin (Nakano et al. 1997; Scott et al. 1997). Aggrecan is the major PG in canine menisci, and its gene expression is reduced by immobilization of the joint (Djurasovic et al. 1998).

The distributions of biglycan and decorin during development and aging of both ligaments and menisci are unknown. There is little immunohistochemically detectable biglycan and decorin in fetal rabbit ligaments and menisci (unpublished observations). Biglycan and decorin and their mRNAs were localized therefore in the collateral and cruciate ligaments and in menisci of the rabbit from 3 weeks postnatal to 2 years. Their distribution between the fiber bundles in the ligaments persists throughout life. In menisci the initial uniform localization changes as fibrocartilage develops. Biglycan is preferentially located in that area. Some cells in these tissues express the mRNAs throughout life.

Materials and Methods

All reagents and labeled antibodies were purchased from Sigma (Poole, UK) and all restriction enzymes, polymerases and yeast tRNA from Roche (Lewes, UK), unless otherwise stated.

Preparation of Tissue for Microscopy

The medial and lateral collateral ligaments, anterior and posterior cruciate ligaments, and lateral and medial menisci were dissected from 3-, 6-, and 12–14-week, 8-month, and 2-year-old rabbit knee joints. Two or more rabbits were used at each stage. The tissues were fixed in 4% paraformaldehyde in 0.05 M Tris-HCl buffer, pH 7.3, for 18 hr, then washed extensively in buffer. After washing, the tissue was dehydrated in graded ethanols, cleared in methyl salicylate, and embedded in paraffin. Serial sagittal longitudinal sections were cut at 7 μm. For histological observations, sections were stained with hematoxylin and eosin.

Figures 1-5 Photomicrographs of the medial collateral ligament of a 6-week-old rabbit.

Figure 1

Bundles of collagen fibers with spindle-shaped cells in rows between them. H&E staining. Bar = 50 μm.

Figure 2

Biglycan (B) antibody binding; biglycan is located primarily between the fiber bundles (arrowheads in a). Bar = 20 μm.

Figure 3

ISH for biglycan mRNA. All cells are expressing the mRNA.

Figure 4

Decorin (D) antibody binding; decorin is located between the fiber bundles (arrowheads in a).

Figure 5

ISH for decorin mRNA. All cells are expressing the mRNA.

Figures 6-10 Photomicrographs of the medial collateral ligament of an 8-month-old rabbit.

Figure 6

Thick bundles of collagen fibrils are interspersed by spindle-shaped cells. H&E staining. Bar = 50 μm.

Figure 7

Biglycan (B) antibody binding; biglycan is located between the fiber bundles.

Figure 8

ISH for biglycan mRNA; only a few scattered cells are expressing the mRNA.

Figure 9

Decorin (D) antibody binding; decorin is located between the fiber bundles.

Figure 10

ISH for decorin mRNA; only a few cells are expressing the mRNA.

Immunohistochemistry

Procedures for Antibodies to Biglycan and Decorin. Chicken polyclonal antibodies to purified bovine biglycan and to purified bovine decorin were a gift from Prof. D. Heinegård (Lund University, Sweden). The total IgG was purified as described by Heinegård et al. (1985).

Sections were dewaxed and rehydrated before the following pretreatments that are usual for paraffin-embedded tissues: (a) 0.1% trypsin in 0.05 M Tris–saline, pH 7.8, with 0.1% CaCl₂ at 37C for 1 hr to aid tissue permeability; (b) 2% hyaluronidase in PBS, pH 7.3, at 37C for 1 hr to remove GAGs and unmask epitopes; (c) 2% l-lysine in PBS for 15 min to reduce charged sites. The sections were washed in PBS between each treatment. To block nonspecific binding, the sections were incubated in heat-inactivated normal rabbit serum (Harlem Sera Labs; Loughborough, UK) with the addition of 4% bovine serum albumin (BSA) and 0.3% Triton X-100 for 30 min. This was drained from the slide and the primary antibody was added at a dilution of 1:1000 in 1% BSA. The sections were incubated overnight at 4C. After washing, the sections were incubated in alkaline phosphatase-labeled rabbit anti-chicken IgG antibodies for 90 min. The alkaline phosphatase label was localized using the following substrate: 5 μg naphthol AS-BI phosphate was dissolved in 1 drop dimethylformamide and added to 5 μg Fast Red TR in 10 ml veronal acetate buffer, pH 9.2. Levamisole (1 μg/ml) was added to inhibit endogenous alkaline phosphatase activity. The sections were incubated in substrate for 20 min, washed, and mounted in glycerin jelly.

For controls the primary antibody was replaced by normal chicken serum. At no time was there any binding in the controls.

In Situ Hybridization

cDNA probes to human biglycan and decorin were a gift from Dr. L. Fisher (NIH; Bethesda, MD) (Fisher et al. 1989); they recognize rabbit biglycan and decorin mRNAs in Northern blots (Demoor–Fossard et al. 1998). Antisense and sense probes were generated by linearizing with Kpn I and T3 polymerase and Xba I and T7 polymerase, respectively, for biglycan and with Bam HI and T7 polymerase and Kpn I and T3 polymerase, respectively, for decorin. Both probes were labeled with digoxigenin by in vitro transcription using the DIG-RNA labeling (SP6/T7) kit (Roche). The riboprobes are 1685 bp (biglycan) and 1600 bp (decorin) long. The transcripts were hydrolyzed at 60C for 40 min in 100 mM bicarbonate buffer to yield fragments of ~200 bp and were stored at –20C until use.

The sections were dewaxed and rehydrated. The following pretreatments were performed: (a) 0.2 N HCl for 20 min; (b) 6% H₂O₂ for 30 min; (c) proteinase K (20 μg/ml) for 10 min at 37C; (d) 4% paraformaldehyde in PBS for 20 min at 4C; (e) 0.1 M glycine twice for 10 min; (f) 0.25% acetic anhydride in triethanolamine (pH 8.0) for 10 min. Between each treatment the sections were washed in PBS. They were then dehydrated through graded ethanols and allowed to dry. Fifteen μl of hybridization solution was applied to each section. The hybridization solution (low stringency) contained 50% formamide, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 1 × Denhardt's, 0.5% SDS, 600 mM NaCl, 10% dextran sulfate, 0.5 μg/ml yeast tRNA, and labeled antisense or sense probe. Hybridization was for 18 hr at 50C for biglycan mRNA and 45C for decorin mRNA. After hybridization, the coverslips were removed in 2 × SSC before rinsing in Tris–EDTA buffer. The sections were then treated with 20 μg/ml RNase in Tris–EDTA–NaCl buffer, pH 8.0. The sections were washed twice in 2 × SSC for 15 min, then in 1 × SSC for 10 min at 55C. A final wash in 1 × SSC was at room temperature. The digoxigenin label was detected using the Roche kit, except that 0.3% Triton X-100 was added to the antibody solution. This blocks the nonspecific binding in the cartilage matrices that arises after treatment with proteolytic enzymes (Bland et al. 1991). The sections were mounted in glycerin jelly.

At no time was there any reaction with the sense, i.e., control, probes.

Results

The results are summarized in Table 1.

Collateral Ligaments

Both lateral and medial collateral ligaments consist of bundles of collagen fibrils with spindle-shaped cells irregularly arranged between the fiber bundles. The number of cells appears to decrease with age (Figures 1 and 6). Antibodies to biglycan and decorin are preferentially bound between the fiber bundles. They tend to be bound more strongly in young ligaments (Figures 2, 4, 7, and 9). Biglycan and decorin mRNAs are expressed by most cells up to 14 weeks, but by 8 months the number of cells expressing the mRNAs has decreased (Figures 3, 5, 8, and 10).

Cruciate Ligaments

The anterior and posterior ligaments are composed of parallel bundles of collagen fibrils separated by rows of large round cells (Figure 11). The binding of antibodies to biglycan and decorin is similar at all ages and is closely associated with the rows of cells (Figures 12 and 14). Among the fibers, the binding is weaker and more variable. Both biglycan and decorin mRNAs are expressed by the cells throughout life (Figures 13 and 15).

Menisci

At 3 weeks postnatal, a fibrocartilaginous region starts to develop in the center of both the lateral and medial menisci (Figure 16) and it is much larger at 8 months (Figure 21). It is surrounded by a dense fibrous layer. At 3 weeks, both antibodies are bound throughout the matrix (Figures 17 and 19). Thereafter, as the fibrocartilaginous regions develop, their PG content changes so that at 8 months these regions strongly bind antibodies to biglycan (Figure 22), whereas antibodies to decorin are bound only in the periphery of the fibrocartilage (Figure 24). Their distributions appear to be mutually exclusive. In non-cartilaginous regions, biglycan antibodies are bound around the cells. Biglycan, but not decorin, antibodies are bound in the surface fibrous tissue. The mRNAs for both biglycan and decorin are expressed by most of the cells at 3 and 6 weeks postnatal (Figures 18 and 20), but with increasing maturity the numbers of cells expressing the mRNAs decreases (Figures 23 and 25).

Figures 11-14 The cruciate ligament of a 6-week-old rabbit.

Figure 11

The bundles of collagen fibers are separated by rows of rounded cells. H&E staining. Bar = 20 μm.

Figure 12

Biglycan (B) antibody binding; biglycan is located primarily around the cells (arrowheads).

Figure 13

ISH for biglycan mRNA; the majority of the cells are expressing the mRNA.

Figure 14

Decorin (D) antibody binding; decorin is located within the fiber bundles and around the cells (arrowheads).

Figure 15

ISH for decorin mRNA; most cells are expressing the mRNA.

Discussion

Ligaments

The lateral and medial collateral ligaments are similar structurally and in their collagen content (Bland and Ashhurst 1996a). Antibodies to biglycan and decorin localize these small PGs between the fiber bundles. Biochemical data suggest that 80% of the PG in mature rabbit medial collateral ligament is decorin, while the remaining 20% is biglycan and a large unidentified PG (Plaas et al. 2000). The immunohistochemical data do not indicate a predominance of decorin over biglycan in mature ligaments.

The cruciate ligaments differ in appearance from the collateral ligaments principally because the cells are round and in prominent rows. Both biglycan and decorin are primarily associated with the cells. The stronger binding of the biglycan antibody compared to that of the decorin antibody may indicate a greater concentration of this PG, but immunohistochemistry cannot be regarded as strictly quantitative.

Over the period from 3 weeks to the mature adult, the distribution of biglycan and decorin in rabbit knee ligaments does not change. Previous studies of PGs of ligaments have been restricted to the localization of their GAGs. Using electron microscopic histochemistry, Bray et al. (1990, 1993) found chondroitin sulfate around the cells and in seams radiating between the bundles of collagen fibrils in human and rabbit medial collateral ligament. This agrees with the distributions of biglycan and decorin reported here.

Figures 16-20 A meniscus of a 3-week-old rabbit.

Figure 16

Random distribution of the cells, but in some internal areas in which fibrocartilage is developing (arrowheads) they are farther apart. H&E staining. Bar = 50 μm.

Figure 17

Biglycan (B) antibody binding; biglycan is present throughout the matrix, but antibody binding is stronger in some surface regions.

Figure 18

ISH for biglycan mRNA; all cells are expressing the mRNA.

Figure 19

Decorin (D) antibody binding; decorin is located throughout the matrix.

Figure 20

ISH for decorin mRNA; all cells are expressing the mRNA.

Figure 21-25 A meniscus of an 8-month-old rabbit.

Figure 21

The central fibrocartilaginous region with chondrocyte-like cells (arrowheads) and the peripheral fibrous layer. H&E staining. Bar = 50 μm.

Figure 22

Biglycan (B) antibody binding; biglycan is present throughout the matrix, but antibody binding is much stronger in the central cartilaginous region.

Figure 23

ISH for biglycan mRNA; only a few cells (arrowheads) are expressing the mRNA.

Figure 24

Decorin (D) antibody binding; decorin is located primarily in a region surrounding the cartilaginous area. Antibody binding is very weak both in the surface layers and in the cartilaginous region.

Figure 25

ISH for decorin mRNA; few cells (arrowheads) are expressing the mRNA.

Menisci

At 3 weeks postnatal, a Type II collagen-containing region develops in the inner part of the rabbit meniscus and persists as fibrocartilage throughout life (Bland and Ashhurst 1996b). At 3 weeks biglycan and decorin are present throughout the fibrocartilage, but by 8 months their distributions are mutually exclusive. Biglycan is present in the center and decorin around the periphery of the fibrocartilage. There are no biochemical data on PGs in rabbit menisci, but data on 20-week porcine menisci indicates that biglycan comprises around 50% and decorin 30% of the small PGs present (Nakano et al. 1997; Scott et al. 1997). This may also be true in rabbits because the area occupied by biglycan is greater than that of decorin. An accumulation of biglycan with increasing age also occurs in rabbit articular cartilage, but here decorin is colocalized with biglycan (Kavanagh and Ashhurst 1999).

Functions of Biglycan and Decorin and Their Association with Collagens

Biglycan is said to be involved in matrix organization, and, together with decorin, in cell–matrix interactions and binding of growth factors (Hildebrand et al. 1994; Buckwalter and Mankin 1997). Decorin binds to both Types I and II collagen and may be involved in the control of fibrillogenesis (Hedbom and Heinegård 1993; Keene et al. 2000; Neame et al. 2000). Developing ligaments are formed primarily of Types I and V collagen; Type III appears in the collateral ligaments at 12 weeks and in the cruciate ligaments at 8 months (Bland and Ashhurst 1996a). In neither the collateral nor the cruciate ligament can the acquisition of Type III collagen be correlated with changes in the biglycan or decorin content. In the 3-week meniscus Types I, III, and V collagen are present throughout the tissue, whereas Type II is just beginning to appear in the central regions (Bland and Ashhurst 1996b). As this central fibrocartilaginous region develops, Type I collagen disappears. The findings presented here show that at 3 weeks both biglycan and decorin are co-localized in the meniscus, but that at 8 months only biglycan is found in the central fibrocartilage. Thus, biglycan colocalizes with Type II and decorin with Type I collagen in the adult rabbit meniscus (compare Figures 22 and 24 with Figures 25 and 26 in Bland and Ashhurst 1996b). The role of decorin in promoting fibrillogenesis must be fulfilled before its loss from the fibrocartilage. The function of biglycan in menisci has been related to the greater compressive forces on the inner region of the meniscus where it predominates (Nakano et al. 1997; Scott et al. 1997).

Expression of Biglycan and Decorin mRNAs

In both the ligaments and menisci, all cells express the mRNAs for biglycan and decorin during growth, i.e., up to 14 weeks, but, except in the cruciate ligaments, only a few cells express the mRNAs by 8 months when the rabbit is skeletally mature. The continuing expression of the mRNAs for biglycan and decorin by a few cells in the adult ligaments and menisci corresponds to our previous observations of rabbit articular cartilage (Kavanagh and Ashhurst 1999). PGs are therefore continually turned over throughout life in contrast to the collagens, whose mRNAs are not expressed by any cells after 8 months (Bland and Ashhurst 1996a,b).

Estimations of mRNA levels in human and rabbit ligaments indicate that expression of biglycan and decorin mRNAs continues throughout life (Boykiw et al. 1998; Lo et al. 1998). Similarly, quantification of biglycan and decorin mRNAs in rabbit knee menisci confirms their continued expression after skeletal maturity (Hellio Le Graverand et al. 1999). After injury, the level of biglycan, but not decorin, mRNA is elevated in both species (Boykiw et al. 1998; Lo et al. 1998). This agrees with the observation that in repairing rabbit medial collateral ligament the amount of biglycan increases, but decorin is barely detectable (Plaas et al. 2000).

Conclusion

Immunohistochemical studies show that matrix components, i.e, collagens, proteoglycans, and other molecules, are distributed in a specific pattern within each tissue. The strength and proper functioning of each ligament and meniscus are dependent on the unique organization of these molecules. During development they are laid down over a protracted period in a precise and sequential manner. The problem for tissue repair is not how to stimulate the cells to secrete the appropriate molecules but how to achieve their correct organization in the regenerated tissues.

Footnotes

Acknowledgements

Supported by the Arthritis and Rheumatism Campaign UK (grant no. A052226).

We thank Prof D. Heinegård for the antibodies, Dr L. Fisher for the cDNA probes, and Ms Y.S. Bland for expert technical assistance.

References

Amiel

Frank

Harwood

Fronek

Akeson

(1984) Tendons and ligaments: a morphological and biochemical comparison. J Orthop Res 1:257–265

Bland

Ashhurst

(1996a) Changes in the distribution of fibrillar collagens in the collateral and cruciate ligaments of the rabbit knee joint during fetal and postnatal development. Histochem J 28:325–334

Bland

Ashhurst

(1996b) Changes in the content of the fibrillar collagens and the expression of their mRNAs in the menisci of the rabbit knee joint during development and ageing. Histochem J 28:265–274

Bland

Ashhurst

(1997) Fetal and postnatal development of the patella and suprapatella in the rabbit: changes in the distribution of the fibrillar collagens. J Anat 190:327–342

Bland

Critchlow

Ashhurst

(1991) Digoxigenin as a probe label for in situ hybridization on skeletal tissues. Histochem J 23:415–418

Boykiw

Sciore

Reno

Marchuk

Frank

Hart

(1998) Altered levels of extracellular matrix molecules mRNA in healing rabbit ligaments. Matrix Biol 17:371–378

Bray

Frank

(1993) Ultrastructural immunolocalization of type-VI collagen and chondroitin sulphate in ligament. J Orthop Res 11:677–685

Bray

Frank

Bray

(1990) Cytochemical evidence for a proteoglycan-associated filamentous network in ligament extracellular matrix. J Orthop Res 8:1–12

Buckwalter

Mankin

(1997) Articular cartilage. Part I. Tissue design and chondrocyte-matrix interactions. J Bone Joint Surg 79A:600–611

10.

Campbell

Tester

Handley

Checkley

Chow

Cant

Winter

Cain

(1996) Characterization of a large chondroitin sulfate proteoglycan present in bovine collateral ligament. Arch Biochem Biophys 329:181–190

11.

Cheung

(1987) Distribution of type I, II, III and V in the pepsin solubilized collagens in bovine meniscus. Connect Tissue Res 16:343–356

12.

Demoor–Fossard

Redini

Boittin

Pujol

J-P

(1998) Expression of decorin and biglycan by rabbit articular chondrocytes. Effects of cytokines and phenotypic modulation. Biochim Biophys Acta 1398:179–199

13.

Djurasovic

Aldridge

Grumbles

Rosenwasser

Howell

Ratcliffe

(1998) Knee joint immobilization decreases aggrecan gene expression in the meniscus. Am J Sports Med 26:460–466

14.

Eyre

(1983) Collagen of fibrocartilage: a distinctive molecular phenotype in bovine meniscus. FEBS Lett 158:265–270

15.

Fisher

Termine

Young

(1989) Deduced protein sequence of small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several unconnected tissue proteins in a variety of species. J Biol Chem 264:4571–4576

16.

Gässler

Tugtekin

Decker

Bosch

Delbrück

(1994) Changes in the extracellular matrix of the autogenous patella tendon graft after posterior cruciate ligament reconstruction: a biochemical study in sheep. Matrix Biol 14:87–99

17.

Hashimoto

Takahashi

Amiel

Coutts

Lotz

(1998) Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 41:1266–1274

18.

Hedbom

Heinegård

(1993) Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 268:27307–27312

19.

Heinegård

Bjorne-Persson

Coster

Franson

Gardell

Malmstrom

Paulsson

Sandfalk

Vogel

(1985) The core proteins of large and small proteoglycans from various connective tissues form distinct subgroups. Biochem J 230:181–194

20.

Hellio Le Graverand

Reno

Hart

(1999) Gene expression in menisci from the knee of skeletally immature and mature female rabbits. J Orthop Res 17:738–744

21.

Hey

Handley

Oakes

(1990) Characterization and synthesis of macromolecules by adult collateral ligament. Biochim Biophys Acta 1034:73–80

22.

Hildebrand

Romaris

Rasmussen

Heinegård

Twardzik

Border

Ruoslahti

(1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β. Biochem J 302:527–534

23.

Kavanagh

Ashhurst

(1999) Development and aging of the articular cartilage of the rabbit knee joint: distribution of biglycan, decorin and matrilin-1. J Histochem Cytochem 47:1603–1615

24.

Keene

San Antonio

Mayne

McQuillan

Sarria

Santoro

Iozzo

(2000) Decorin binds near the C-terminus of type I collagen. J Biol Chem 275:21801–21804

25.

Marchuk

Hart

Frank

(1998) Comparison of mRNA levels for matrix molecules in normal and disrupted human anterior cruciate ligaments using reverse transcription-polymerase chain reaction. J Orthop Res 16:421–428

26.

McDevitt

Webber

(1990) The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop 252:8–18

27.

Nakano

Dodd

Scott

(1997) Glycosaminoglycans and proteoglycans from different zones of the porcine knee meniscus. J Orthop Res 15:213–220

28.

Neame

Kay

McQuyillan

Beales

Hassell

(2000) Independent modulation of collagen fibrillogenesis by decorin and lumican. Cell Mol Life Sci 57:859–863

29.

Neidel

Schroers

Sintermann

(1998) The effects of high-dose methotrexate on the development of cartilage lesions in a lapine model of osteoarthritis. Arch Orthop Trauma Surg 117:265–269

30.

Plaas

Wong–Palms

Koob

Hernandez

Marchuk

Frank

(2000) Proteoglycan metabolism during repair of the ruptured medial collateral ligament in skeletally mature rabbits. Arch Biochem Biophys 374:35–41

31.

Pond

Nuki

(1973) Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis 32:387–388

32.

Scott

Nakano

Dodd

(1997) Isolation and characterization of small proteoglycans from different zones of the porcine knee meniscus. Biochim Biophys Acta 1336:254–262

33.

Watanabe

Nojima

Shibata

Hamada

(1994). Maturation-related biochemical changes in swine anterior cruciate ligament and tibialis posterior tendon. J Orthop Res 12:672–682

34.

Webber

Norby

Malemud

Goldberg

Moskowitz

(1984) Characterization of newly synthesized proteoglycans from rabbit menisci in organ culture. Biochem J 221:875–884